With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
June 15, 2017. Ever wonder if you can get generic trastuzumab? Enter biosimilars, aka generic biological agents. Biosimilars offer the possibility of making targeted agents more widely available and less burdensome on our healthcare budgets. Unfortunately, the science and economics of the biosimilars market has proven to be quite complex. We talk a lot about ways to save healthcare dollars, and biosimilars could be a HUGE step in the right direction...making this concise viewpoint in last week’s JAMA Onc worth the read.